Journal article
Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
- Abstract:
-
The leading malaria vaccine in development is the circumsporozoite (CS) protein-based vaccine, RTS,S, which targets the pre-erythrocytic stage of Plasmodium falciparum infection. It induces modest levels of protective efficacy largely mediated by CS specific antibodies. We aimed to enhance vaccine efficacy by generating a potentially more immunogenic CS-based particle vaccine and developed a next-generation RTS,S-like vaccine, called R21. The major improvement is that in contrast to RTS,S, R2...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
+ Wellcome Trust
More from this funder
Funding agency for:
Hill, A
Grant:
Wellcome Senior Investigator
Bibliographic Details
- Publisher:
- Nature Publishing Group Publisher's website
- Journal:
- Scientific Reports Journal website
- Volume:
- 7
- Pages:
- 46621
- Publication date:
- 2017-04-01
- Acceptance date:
- 2017-03-03
- DOI:
- ISSN:
-
2045-2322
Item Description
- Pubs id:
-
pubs:685488
- UUID:
-
uuid:fa5080e4-b03e-4170-a0fd-4f2a626cd908
- Local pid:
- pubs:685488
- Deposit date:
- 2017-03-13
Terms of use
- Copyright holder:
- Gilbert et al
- Copyright date:
- 2017
- Notes:
- © The Author(s) 2017. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record